Cargando…
Utilization of innovative medical technologies in German inpatient care: does evidence matter?
BACKGROUND: The reimbursement of new technologies in inpatient care is not always linked to a requirement for evidence-based evaluation of patient benefit. In Germany, every new technology approved for market was until recently eligible for reimbursement in inpatient care unless explicitly excluded....
Autores principales: | Eckhardt, Helene, Felgner, Susanne, Dreger, Marie, Fuchs, Sabine, Ermann, Hanna, Rödiger, Hendrikje, Rombey, Tanja, Busse, Reinhard, Henschke, Cornelia, Panteli, Dimitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546629/ https://www.ncbi.nlm.nih.gov/pubmed/37784100 http://dx.doi.org/10.1186/s12961-023-01047-w |
Ejemplares similares
-
Implementation of innovative medical technologies in German inpatient care: patterns of utilization and evidence development
por: Dreger, Marie, et al.
Publicado: (2021) -
Correction to: Implementation of innovative medical technologies in German inpatient care: patterns of utilization and evidence development
por: Dreger, Marie, et al.
Publicado: (2022) -
Digital health applications and the fast-track pathway to public health coverage in Germany: challenges and opportunities based on first results
por: Lantzsch, Hendrikje, et al.
Publicado: (2022) -
Correction: Digital health applications and the fast-track pathway to public health coverage in Germany: challenges and opportunities based on first results
por: Lantzsch, Hendrikje, et al.
Publicado: (2023) -
A country-level analysis comparing hospital capacity and utilisation during the first COVID-19 wave across Europe()
por: Berger, Elke, et al.
Publicado: (2022)